Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women

I. Ingemarsson; D. Wide-Swensson; K. E. Andersson; S. Arulkumaran

doi:10.2165/00003495-199000402-00014

Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women

I. Ingemarsson, D. Wide-Swensson, K. E. Andersson, S. Arulkumaran

Medical School

Lund University

Research output: Contribution to journal › Article › peer-review

Abstract

The results suggest that isradipine might be a suitable drug for antihypertensive treatment in pregnancy. Intravenous bolus injections had no adverse effects on fetal circulation and, in contrast to other calcium antagonists of a similar type, had little effect on uterine activity. Doses of isradipine 0.3mg promptly normalised blood pressure in hypertensive pregnant women.

Original language	English
Pages (from-to)	58-59
Number of pages	2
Journal	Drugs
Volume	40
Issue number	2
DOIs	https://doi.org/10.2165/00003495-199000402-00014
Publication status	Published - 1990

Access to Document

10.2165/00003495-199000402-00014

Cite this

@article{dec1c0ad8ab54bee9e3668dca5a31c02,

title = "Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women",

abstract = "The results suggest that isradipine might be a suitable drug for antihypertensive treatment in pregnancy. Intravenous bolus injections had no adverse effects on fetal circulation and, in contrast to other calcium antagonists of a similar type, had little effect on uterine activity. Doses of isradipine 0.3mg promptly normalised blood pressure in hypertensive pregnant women.",

author = "I. Ingemarsson and D. Wide-Swensson and Andersson, \{K. E.\} and S. Arulkumaran",

year = "1990",

doi = "10.2165/00003495-199000402-00014",

language = "English",

volume = "40",

pages = "58--59",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis",

number = "2",

}

TY - JOUR

T1 - Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women

AU - Ingemarsson, I.

AU - Wide-Swensson, D.

AU - Andersson, K. E.

AU - Arulkumaran, S.

PY - 1990

Y1 - 1990

N2 - The results suggest that isradipine might be a suitable drug for antihypertensive treatment in pregnancy. Intravenous bolus injections had no adverse effects on fetal circulation and, in contrast to other calcium antagonists of a similar type, had little effect on uterine activity. Doses of isradipine 0.3mg promptly normalised blood pressure in hypertensive pregnant women.

AB - The results suggest that isradipine might be a suitable drug for antihypertensive treatment in pregnancy. Intravenous bolus injections had no adverse effects on fetal circulation and, in contrast to other calcium antagonists of a similar type, had little effect on uterine activity. Doses of isradipine 0.3mg promptly normalised blood pressure in hypertensive pregnant women.

UR - https://www.scopus.com/pages/publications/0025081504

U2 - 10.2165/00003495-199000402-00014

DO - 10.2165/00003495-199000402-00014

M3 - Article

C2 - 2150643

AN - SCOPUS:0025081504

SN - 0012-6667

VL - 40

SP - 58

EP - 59

JO - Drugs

JF - Drugs

IS - 2

ER -

Maternal and Fetal Cardiovascular Changes After Intravenous Injections of Isradipine to Pregnant Women

Abstract

Access to Document

Other files and links

Fingerprint

Cite this